Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
AVAPRO | 300MG | TABLET | Resolved | 2020-03-12 | 2020-04-22 | 108533 |
IRBESARTAN | 300MG | TABLET | Resolved | 2020-03-17 | 2020-07-02 | 108850 |
AVAPRO | 75MG | TABLET | Resolved | 2020-04-07 | 2020-06-29 | 111392 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-04-10 | 2021-03-04 | 111865 |
AVAPRO | 150MG | TABLET | Resolved | 2020-07-10 | 2020-07-15 | 119930 |
TEVA-IRBESARTAN HCTZ | 25MG 300MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120235 |
IRBESARTAN | 75MG | TABLET | Resolved | 2020-08-07 | 2020-08-20 | 121934 |
SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124600 |
SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124606 |
SANDOZ IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124609 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |
MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
VAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58386 |
VAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58389 |